Novartis receives FDA approval for Zortress
- April 22, 2010
The US Food and Drug Administration (FDA) has approved Zortress oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be ... Read More